Paul B. Manning, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), bought 750,000 shares at $2.75 ($2.1M) on 2025-05-30, disclosed to the SEC on 2025-06-03.
Open-market purchase of $2.1M TSHA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| CADL | BUY | 2024-12-18 | $7.5M | — | Filing → |